Pulmonary Arterial Hypertension clinical trials

Explore recruiting pulmonary arterial hypertension clinical trials.

Recruiting pulmonary arterial hypertension studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary Arterial Hypertension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002

Portugal, Italy, Sweden, Czechia, Ireland, France +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hypertension (PAH)

Czechia, Ireland, Poland, Latvia, Portugal, Greece +8 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension

Belgium, Italy, Spain, Denmark, Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hypertension (TROPOS-Study)

Germany, Portugal, Poland, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Effects of DAPAgliflozin on cardiopulmonary exercise capacity and hemodynamics in Pulmonary Arterial Hypertension: A double blind randomized trial. (DAPAH-trial)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter, open-label, randomized study with single-arm extension period to assess the pharmacokinetics, safety and efficacy of macitentan versus standard of care in children with pulmonary arterial hypertension

Portugal, Hungary, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pulmonary Arterial Hypertension trials by city

Pulmonary Arterial Hypertension in Toronto Pulmonary Arterial Hypertension in Vancouver Pulmonary Arterial Hypertension in Montreal Pulmonary Arterial Hypertension in Calgary Pulmonary Arterial Hypertension in Edmonton Pulmonary Arterial Hypertension in Ottawa Pulmonary Arterial Hypertension in Winnipeg Pulmonary Arterial Hypertension in Quebec City Pulmonary Arterial Hypertension in Hamilton Pulmonary Arterial Hypertension in Kitchener Pulmonary Arterial Hypertension in London Pulmonary Arterial Hypertension in Halifax Pulmonary Arterial Hypertension in New York Pulmonary Arterial Hypertension in Los Angeles Pulmonary Arterial Hypertension in Chicago Pulmonary Arterial Hypertension in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease